Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
by Gene Marcial on Jan.24, 2011, under Towing
Lpath focuses on developing therapeutics that target bioactive lipids for treating a range of human diseases, including cancer and diseases that cause blindness. Its promising drugs have attracted attention — and lots of money — from Pfizer. More of both could be coming.
Continue reading Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer originally appeared on DailyFinance on Mon, 24 Jan 2011 07:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Pfizer, Stock Picks



